Charles River Laboratories International (CRL) 10-Q2005 Q1 Quarterly report

Filed: 4 May 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: American, announced, APB, appraisal, appraiser, approach, awaiting, backlog, bioanalytical, brand, chemistry, client, complement, consent, constant, Creation, delayed, depend, Derivative, distribution, driven, DSO, duration, earned, extended, extent, fulfillment, II, inhalation, instance, intention, intrinsic, lower, maintain, make, metabolic, modified, modify, optimizing, penalty, pharmacokinetic, Phase, policy, proceed, proportion, prospective, Proteomic, rapid, refinement, removed, repatriate, reproductive, scope, short, standard, strategy, study, talent, temporary, track, turnaround, unified, variety, vary, varying, written

Removed: acquire, adding, additional, adverse, Ajinomoto, andin, annually, appeal, area, asserted, August, award, awarded, balance, bankruptcy, billion, borrow, breach, buyer, California, called, CD, claim, clause, closed, commencing, Commercial, commitment, contingently, Court, declined, deposited, Diego, disposal, dispute, DST, end, essentially, Europe, exit, expansion, expenditure, fee, filed, final, finance, force, France, French, generated, holding, improvement, indemnification, initial, insufficient, issuable, January, Japan, joint, labor, leasehold, level, locate, low, Lyon, machinery, managed, manner, manufacturing, marketability, Maryland, meet, moderated, monthly, multiplied, negatively, original, originated, outsourced, ownership, percent, performance, point, previously, privately, production, pursuant, recover, recovery, remaining, rental, Reserve, reset, restructuring, retain, retained, retention, RVF, safety, San, sensitivity, separated, separation, settled, settlement, simplify, slower, spread, Springborn, Statutory, stayed, subcontractor, sublease, subordinated, subsidiary, sufficient, Supreme, technical, termination, unable, understanding, undiscounted, undrawn, unsecured, vaccine, venture, worldwide, write, yen

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CRL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q for the period ended March 26, 2005 of Charles River Laboratories International, Inc. (the "Company") as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, James C. Foster, the Chairman, Chief Executive Officer and President, and Thomas F. Ackerman, Corporate Senior Vice President and Chief Financial Officer, each hereby certifies, to the best of his knowledge and pursuant to 18 U.S.C. Section 1350, that:

(1): the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2): the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 4, 2005		/s/ JAMES C. FOSTER James C. Foster Chairman, Chief Executive Officer & President Charles River Laboratories International, Inc.
Dated: May 4, 2005		/s/ THOMAS F. ACKERMAN Thomas F. Ackerman Senior Vice President & Chief Financial Officer Charles River Laboratories International, Inc.

QuickLinks

Exhibit 32.1